ENTRY INTO JAPANESE MARKET
Creating Opportunities for Orphan Drugs
to Enter the Japanese Market
OrphanPacific is a Japanese pharmaceutical company dedicated to bringing orphan drugs to patients across Japan. We provide solutions for overseas pharmaceutical companies and biotech firms to enter the Japanese market.
Japan is one of the leading countries in terms of regulatory systems for drug development and approval, as well as a healthcare insurance system that offers universal coverage. Learn more about “Opportunities for Orphan Drugs in Japan.”
Opportunities for Orphan Drugs in Japan
Key Challenges to Entering the Japanese Pharma Market
In Japan, pharmaceutical regulations, pricing systems, and specific requirements for product quality and supply differ from those in the US and EU. OrphanPacific is committed to providing valuable and innovative solutions to introduce orphan drugs to the Japanese market. Our mission is to bring smiles and happiness to patients with rare diseases and their families.
